Cargando…
Gut microbiome homeostasis and the future of probiotics in cancer immunotherapy
The gut microbiome has an impact on cancer immune surveillance and immunotherapy, with recent studies showing categorical differences between immunotherapy-sensitive and immunotherapy-resistant cancer patient cohorts. Although probiotics are traditionally being supplemented to promote treatments or...
Autores principales: | Singh, Ankita, Alexander, Sharon Grace, Martin, Sunil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228691/ https://www.ncbi.nlm.nih.gov/pubmed/37261348 http://dx.doi.org/10.3389/fimmu.2023.1114499 |
Ejemplares similares
-
Gut Microbiome as a Potential Factor for Modulating Resistance to Cancer Immunotherapy
por: Shui, Lin, et al.
Publicado: (2020) -
Probiotics and Probiotic-Derived Functional Factors—Mechanistic Insights Into Applications for Intestinal Homeostasis
por: Yan, Fang, et al.
Publicado: (2020) -
Probiotics maintain the gut microbiome homeostasis during Indian Antarctic expedition by ship
por: Srivastava, Ashish Kumar, et al.
Publicado: (2021) -
The future of affordable cancer immunotherapy
por: Schaft, Niels, et al.
Publicado: (2023) -
The Role of the Gut Microbiome in Cancer Immunotherapy: Current Knowledge and Future Directions
por: Kiousi, Despoina E., et al.
Publicado: (2023)